spec sheet7 rows
Alfacalcidol is a pre-activated vitamin D analogue used when the kidney cannot perform the final hydroxylation itself.
- A vitamin D analogue that comes already activated
- Bypasses the kidney hydroxylation step entirely
- The correct choice when the kidney cannot make that conversion
- Also right where parathyroid hormone is missing
- Dosing guided by measured serum calcium, precise and checkable
- One step closer to active calcitriol than plain vitamin D
- Alfacalcidol is a prodrug of calcitriol that needs only hepatic 25-hydroxylation, not renal 1-alpha-hydroxylation, which is precisely why it is used in renal failure and hypoparathyroidism where cholecalciferol cannot be activated.
- In a head-to-head 18-month randomised trial in glucocorticoid-induced osteoporosis, alendronate raised lumbar spine BMD by 2.1% while alfacalcidol LOST 1.9%, a 4.0% difference favouring the bisphosphonate [1].
- A systematic review of calcitriol and alfacalcidol found evidence for reduction in falls and some fracture endpoints, but also a clear excess of hypercalcaemia compared with plain vitamin D [2].
- Alfacalcidol has a genuine muscle and balance signal distinct from its bone effect, reported in elderly patients with reduced bone mass (PMID 20827552, PMID 16172518).
- Because alfacalcidol is already 1-alpha-hydroxylated, serum 25(OH)D is NOT a valid monitoring test for it; serum and urinary calcium are the monitoring parameters.
Mechanism
Ordinary vitamin D needs two hydroxylations, in the liver and then at the 1-alpha position in the kidney, and the renal step is the regulated one. Alfacalcidol arrives already hydroxylated at position 1, so it only needs the liver to make calcitriol. That is why it works in renal failure and hypoparathyroidism, and it is also why the body's own safety brake on activation is absent.
receptor fingerprint
Vitamin D receptor (VDR / NR1I1)Agonist, acting through the calcitriol formed after hepatic activation
Skeletal muscle VDRAgonist; improves type II fibre function
Hepatic 25-hydroxylase (CYP2R1 / CYP27A1)Substrate; 1-alpha-hydroxyvitamin D3 is 25-hydroxylated in the liver to 1,25-dihydroxyvitamin D3 (calcitriol)
Intestinal calcium absorption machinery (TRPV6, calbindin-D9k, PMCA1b)Transcriptional upregulation
Parathyroid hormone secretionSuppression via parathyroid VDR and raised serum calcium
Safetyrisks and cautions, not medical advice
An activated vitamin D analogue that bypasses renal regulation, so it causes hypercalcaemia far more readily than plain vitamin D and is dosed against serum calcium rather than by feel.
Subjective profileweighing the evidence above
Anyone reaching for this as a stronger vitamin D has misunderstood what it is. Skipping the renal hydroxylation step is not a bonus feature; that step is the regulator, and removing it is exactly why serum calcium has to be measured rather than assumed. It is the correct choice when the kidney cannot perform that conversion or when parathyroid hormone is missing, and the wrong choice for ordinary insufficiency, where plain colecalciferol is cheaper, safer and self limiting.
Where to buy
Suppliers
Vendors carrying Alfacalcidol, with live product details and codes. Links are affiliate links that support the wiki at no cost to you.
RUPharma🌐
Alfacalcidol
Research
- 2005first citedThe therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of f…
- 2008meta-analysisSystematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and fa…
- 2022most recentJintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporos…
- 1.Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
- 2.Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls.
- 3.Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass.
- 4.Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial.
- 5.The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
- 6.D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management.
6 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
Notes and cautions
- The dominant risk is hypercalcaemia and hypercalciuria, which can progress to nephrocalcinosis, renal impairment and, at extremes, cardiac arrhythmia; serum calcium must be monitored, more often during dose titration.
- Because alfacalcidol bypasses the renal activation step, it has no physiological feedback brake, so it is far easier to overshoot with than plain cholecalciferol; do not stack it with high-dose vitamin D, calcium supplements or thiazide diuretics without monitoring.
- It is inferior to a bisphosphonate for preventing glucocorticoid-induced bone loss and should not be substituted for one in that setting [1].
- Magnesium-containing antacids should be avoided in dialysis patients on alfacalcidol because of hypermagnesaemia risk.